-Lewis C Cantley Researcher Activity Profile

Research Author Detailed Information 

Lewis C Cantley Publication Rate By Year

Lewis C Cantley has published 1 paper(s) in 1994, 1 paper(s) in 1997, 1 paper(s) in 2006, 14 paper(s) in 2007, 3 paper(s) in 2008, for a total of 20 research publications in total.

Lewis C Lc Cantley Author Information

LAST NAME: cantley

FIRST NAME: Lewis C

INITIALS: lc

AFFILIATION:

Papers

Lewis C Cantley's Publication Record

1. Determining protein kinase substrate specificity by parallel solution-phase assay of large numbers of peptide substrates. Year Published: 2007
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. ben.turk@yale.edu
2. AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo. Year Published: 2007
Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
3. Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. Year Published: 2006
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
4. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Year Published: 2007
Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA.
5. In-gel stable isotope labeling for relative quantification using mass spectrometry. Year Published: 2007
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA. jasara@bidmc.harvard.edu
6. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Year Published: 2007
Department of Molecular Biology and Biochemistry, University of California, Irvine 92697-3900, USA.
7. Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Year Published: 2007
Beth Israel Deaconess Medical Center (Signal Transduction and Cardiovascular Divisions), Boston, MA 02115, USA.
8. AKT/PKB signaling: navigating downstream. Year Published: 2007
Department of Genetics and Complex Diseases, Harvard School of Public Health, SPH2-117, Boston, MA 02115, USA. bmanning@hsp.harvard.edu
9. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Year Published: 2007
Department of Pathology, Case Western Reserve University School of Medicine, Room 5123 Wolstein Research Building, Cleveland, OH 44106, and Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. dwa4@case.edu
10. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Year Published: 2007
Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
11. Cloning and characterization of a human phosphatidylinositol 4-kinase. Year Published: 1994
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.
12. Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase. Year Published: 1997
Department of Cell Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Hospital, Boston, Massachusetts 02215, USA.
13. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Year Published: 2007
Department of Pathology, Case Western Reserve University School of Medicine, Room 5123 Wolstein Research Building, Cleveland, OH 44106, and Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. dwa4@case.edu
14. Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry. Year Published: 2007
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. jasara@bidmc.harvard.edu
15. Fate of a bioactive fluorescent wortmannin derivative in cells. Year Published: 2008
ljosephson@partners.org.
16. Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry. Year Published: 2007
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. jasara@bidmc.harvard.edu
17. Fate of a bioactive fluorescent wortmannin derivative in cells. Year Published: 2008
ljosephson@partners.org.
18. In-gel stable isotope labeling for relative quantification using mass spectrometry. Year Published: 2007
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA. jasara@bidmc.harvard.edu
19. Determining protein kinase substrate specificity by parallel solution-phase assay of large numbers of peptide substrates. Year Published: 2007
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. ben.turk@yale.edu
20. Fate of a bioactive fluorescent wortmannin derivative in cells. Year Published: 2008
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, 149, 13th Street, Charlestown, Massachusetts 02129, USA.